Dan needed a miracle. At this point, he’d had six surgeries on his neck, endured radiation therapy, and been enrolled in five clinical trials. Dan’s miracle came in 2006 in the form of an experimental drug, ipilimumab or anti-CTLA4 antibody, that would later be named Yervoy.
It’s easy to think of sunscreen when you are lounging by a pool, but did you know that it’s important to protect yourself and those you love every day of the year? That’s why MRA partnered with the Melanoma Action Coalition to create #SunSavvy365, a social media campaign that reminds us to protect our skin whether we are making sand castles or snowmen.
The Melanoma Research Alliance (MRA) is pleased to announce its 2018 – 2019 Request for Proposals for preclinical, translational and early clinical research with the power to transform melanoma prevention, detection, staging, and treatment.
The 2018 - 2019 award cycle is anticipated to support at least $9 million in funding. Proposals will be accepted for Established Investigator Awards, Pilot Awards, and Young Investigator Awards.
For Derrick, it all started with headaches. For the first time in his life, this otherwise perfectly healthy father of two, knew something was wrong.
When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.
08/06/2018 – MRA 2018-2019 Request for Proposals Now Available
07/16/2018 – Applying AI to Melanoma Detection
06/27/2018 – MRA Applauds Latest Melanoma Drug Approval
